![High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design | Scientific Reports High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-22382-x/MediaObjects/41598_2018_22382_Fig1_HTML.jpg)
High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design | Scientific Reports
![Frontiers | NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments | Pharmacology Frontiers | NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments | Pharmacology](https://www.frontiersin.org/files/Articles/708302/fphar-12-708302-HTML/image_m/fphar-12-708302-g001.jpg)
Frontiers | NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments | Pharmacology
![Frontiers | The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study | Pharmacology Frontiers | The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study | Pharmacology](https://www.frontiersin.org/files/Articles/469420/fphar-10-00908-HTML/image_m/fphar-10-00908-g001.jpg)
Frontiers | The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study | Pharmacology
![Cancers | Free Full-Text | Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles | HTML Cancers | Free Full-Text | Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles | HTML](https://www.mdpi.com/cancers/cancers-12-00144/article_deploy/html/images/cancers-12-00144-ag.png)
Cancers | Free Full-Text | Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles | HTML
![Is it time to introduce anti-inflammatory drugs into secondary cardiovascular prevention: evidence from clinical trials? Is it time to introduce anti-inflammatory drugs into secondary cardiovascular prevention: evidence from clinical trials?](https://oaepublishstorage.blob.core.windows.net/0f515c1e-6a9c-4191-aa4d-dec70b610ef4/3942.fig.1.jpg)
Is it time to introduce anti-inflammatory drugs into secondary cardiovascular prevention: evidence from clinical trials?
Colchicine en antiinflammatoire therapie in secundaire cardiovasculaire preventie | Tijdschrift voor Cardiologie
![GEF-H1 Is Required for Colchicine Inhibition of Neutrophil Rolling and Recruitment in Mouse Models of Gout | The Journal of Immunology GEF-H1 Is Required for Colchicine Inhibition of Neutrophil Rolling and Recruitment in Mouse Models of Gout | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/205/12/3300/F3.medium.gif)
GEF-H1 Is Required for Colchicine Inhibition of Neutrophil Rolling and Recruitment in Mouse Models of Gout | The Journal of Immunology
![An engineered lipocalin that tightly complexes the plant poison colchicine for use as antidote and in bioanalytical applications An engineered lipocalin that tightly complexes the plant poison colchicine for use as antidote and in bioanalytical applications](https://www.degruyter.com/document/doi/10.1515/hsz-2018-0342/asset/graphic/j_hsz-2018-0342_fig_001.jpg)